Javascript must be enabled to continue!
Abstract 1635: MiR-21/Smad 7 signaling determines TGF-β1-induced cancer associated fibroblast (CAF) formation.
View through CrossRef
Abstract
Tumor-secreted growth factors such as TGF-β1 transform adjacent normal fibroblasts into cancer-associated fibroblasts (CAF) which is a major source of CAF. TGF-β1 has canonical and noncanonical Smad pathway, which pathway mediates TGF-β1 signaling during the CAF formation and how TGF-β1 activates regulatory Smad proteins is not entirely understood. To investigate whether the miR-21/Smad 7 signaling determines TGF-β1-induced CAF formation, the in vitro TGF-β1-induced CAF model was successfully established and the function of fibroblasts knocked down or overexpressed miR-21 or Smad 7 were finally identified in the xenografted mice, with or without TGF-β1 stimulation. Our data showed that the mature miR-21 is increased in fibroblast after TGF-β1 treatment, and miR-21 regulates Smad 7 protein level through the translation inhibition instead of the mRNA decay. Moreover, our data showed Smad 3 was phosphorylated 2 hours early than Smad 2 after TGF-β1 stimulation and Smad
7 knockdown enhanced Smad 2 and 3 phosphorylation; both of their phosphorylations were abolished by the TGFR kinase inhibitor. Most important, both of the over-expression of miR-21 or the knockdown of Smad 7 promoted CAF formation, even without TGF-β1 stimulation while the miR-21 knockdown or the Smad 7 overexpression as well as Smad 2, 3 and Smad 4 knock down blocked the TGF-β1-induced CAF formation.
These observations suggest that TGF-β1 induces CAF formation through the canonical pathway, miR-21/Smad 7 is a critical mediator.
Citation Format: Qiong Li, Yongbin Wang, Wujun Xiong, Jun Mi. MiR-21/Smad 7 signaling determines TGF-β1-induced cancer associated fibroblast (CAF) formation. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1635. doi:10.1158/1538-7445.AM2013-1635
Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.
American Association for Cancer Research (AACR)
Title: Abstract 1635: MiR-21/Smad 7 signaling determines TGF-β1-induced cancer associated fibroblast (CAF) formation.
Description:
Abstract
Tumor-secreted growth factors such as TGF-β1 transform adjacent normal fibroblasts into cancer-associated fibroblasts (CAF) which is a major source of CAF.
TGF-β1 has canonical and noncanonical Smad pathway, which pathway mediates TGF-β1 signaling during the CAF formation and how TGF-β1 activates regulatory Smad proteins is not entirely understood.
To investigate whether the miR-21/Smad 7 signaling determines TGF-β1-induced CAF formation, the in vitro TGF-β1-induced CAF model was successfully established and the function of fibroblasts knocked down or overexpressed miR-21 or Smad 7 were finally identified in the xenografted mice, with or without TGF-β1 stimulation.
Our data showed that the mature miR-21 is increased in fibroblast after TGF-β1 treatment, and miR-21 regulates Smad 7 protein level through the translation inhibition instead of the mRNA decay.
Moreover, our data showed Smad 3 was phosphorylated 2 hours early than Smad 2 after TGF-β1 stimulation and Smad
7 knockdown enhanced Smad 2 and 3 phosphorylation; both of their phosphorylations were abolished by the TGFR kinase inhibitor.
Most important, both of the over-expression of miR-21 or the knockdown of Smad 7 promoted CAF formation, even without TGF-β1 stimulation while the miR-21 knockdown or the Smad 7 overexpression as well as Smad 2, 3 and Smad 4 knock down blocked the TGF-β1-induced CAF formation.
These observations suggest that TGF-β1 induces CAF formation through the canonical pathway, miR-21/Smad 7 is a critical mediator.
Citation Format: Qiong Li, Yongbin Wang, Wujun Xiong, Jun Mi.
MiR-21/Smad 7 signaling determines TGF-β1-induced cancer associated fibroblast (CAF) formation.
[abstract].
In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC.
Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1635.
doi:10.
1158/1538-7445.
AM2013-1635
Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.
Related Results
Abstract 4706: Gene and protein expression of TGF-beta signaling pathway molecules in women undergoing reduction mammoplasty
Abstract 4706: Gene and protein expression of TGF-beta signaling pathway molecules in women undergoing reduction mammoplasty
Abstract
Gene and protein expression of TGF-beta signaling pathway molecules in women undergoing reduction mammoplasty.
Introduction: The TGF- β signa...
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
Objectives
The activation of coagulation and fibrinolysis plays a critical role in the incidence of coronary events. MicroRNAs (miRNAs) are small non-coding ribon...
KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression
KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression
AbstractInhibition of tumor suppressive signaling is linked to cancer progression, metastasis and epithelial–mesenchymal transition (EMT). Transforming growth factor-β1 (TGF-β)/Sma...
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
AbstractMicroRNAs are a class of non‐coding molecules found to regulate a variety of cellular functions in health and disease. Dysregulation of microRNAs is involved in liver disea...
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
Introduction: Acute myocardial infarction (AMI) is a severe coronary heart disease. Targeted miRNAs studies implicated two main pathways in the regulation of AMI namely pro-apopt...
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
Abstract
Background
MicroRNAs (miRNAs) can function as either oncogenes or tumor suppressor genes via regulation of cell proliferation and/or apo...
Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation
Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation
<b><i>Background:</i></b> Atrial fibrosis plays a critical role in the occurrence and maintenance of atrial fibrillation. The role of TGF-β1 in mediating at...
Ethyl Acetate Extract from Wenxia Formula (WFEA) Attenuates Immunosuppression in Lung Cancer by Inhibiting Treg Differentiation via Blockade of TGF-Β/Smad Signaling
Ethyl Acetate Extract from Wenxia Formula (WFEA) Attenuates Immunosuppression in Lung Cancer by Inhibiting Treg Differentiation via Blockade of TGF-Β/Smad Signaling
Introduction:
The ethyl acetate extract of Wenxia Formula (WFEA) is the most effective
antitumor component of the Wenxia formula. Its key active components, emo...

